Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M62,513Revenue $M17,005Net Margin (%)17.4Z-Score4.1
Enterprise Value $M61,351EPS $3.0Operating Margin %21.3F-Score5
P/E(ttm))21.7Cash Flow Per Share $4.4Pre-tax Margin (%)21.1Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %7.7Quick Ratio3.5Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %2.9Current Ratio3.8Lower Leverage y-yY
Price/Cash Flow9.7y-y EBITDA Growth Rate %-10.5ROA % (ttm)8.1Higher Current Ratio y-yN
Dividend Yield %1.9Insider Buy (3m)0ROE % (ttm)15.7Less Shares Outstanding y-yY
Payout Ratio %39.0Shares Outstanding M980ROI % (ttm)3.1Gross Margin Increase y-yN

Gurus Latest Trades with MDT

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

MDT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MDT Jean-Marie Eveillard 2014-06-302,098,3430.210.32New Buy
MDT Mario Gabelli 2014-06-3040,00000.01New Buy
MDT Robert Olstein 2014-06-30115,0000.010.99New Buy
MDT Vanguard Health Care Fund 2014-06-3012,402,0001.272.1+9.39%
MDT James Barrow 2014-06-3032,340,2343.32.8+1.96%
MDT Bill Nygren 2014-06-304,605,0000.472.1+0.44%
MDT Scott Black 2014-06-3042,98300.4-0.16%
MDT John Keeley 2014-06-3033,46000.04-2.05%
MDT Dodge & Cox 2014-06-308,776,5930.90.53-2.29%
MDT PRIMECAP Management 2014-06-3029,602,2283.022.1-6.23%
MDT HOTCHKIS & WILEY 2014-06-301,932,5000.20.44-6.5%
MDT Ken Fisher 2014-06-306,01500-12.23%
MDT Joel Greenblatt 2014-06-309,39800.01-96.16%
MDT Ray Dalio 2014-06-30000Sold Out
MDT John Hussman 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


MDT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc 2014-10-09Sell370$64.07-3.25view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-10-06Sell15,388$64.98-4.6view
COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc 2014-10-03Sell571$65.03-4.67view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-08-26Sell28,000$63.57-2.49view
JACKSON SHIRLEY ADirector 2014-08-26Sell2,769$63.66-2.62view
Szyman Catherine MSrVP & Pres Diabetes 2014-04-17Sell29,420$58.795.44view
Kuntz RichardSrVP & Chief Scien, Clin, Reg 2014-04-09Sell2,512$60.981.66view
Ellis Gary LeeSrVP & CFO 2014-04-01Sell4,246$61.480.83view
OConnell Christopher JEVP & GroupPres Restora Therap 2014-03-28Sell1,982$60.392.65view
Szyman Catherine MSrVP & Pres Diabetes 2014-03-20Sell14,979$59.574.06view

Press Releases about MDT :

    Quarterly/Annual Reports about MDT:

    News about MDT:

    Articles On GuruFocus.com
    EW: Potential for Capital Appreciation Oct 03 2014 
    Medical Technology Company Offers Investment Opportunity Sep 25 2014 
    Medtronic Inc. (MDT) Dividend Stock Analysis Sep 12 2014 
    Paulson, Mindich and Soros Bought Covidien; Should You? Sep 11 2014 
    Abbott: A Brighter Future Aug 28 2014 
    Jeff Auxier Second Quarter Shareholder Letter Aug 08 2014 
    Outlook for August 2014 Aug 01 2014 
    Mairs & Power Balanced Fund Second Quarter 2014 Commentary Jul 31 2014 
    Bill Frels Comments on Medtronic Inc Jul 31 2014 
    Bill Frels' Mairs & Power Growth Fund Second Quarter 2014 Commentary Jul 31 2014 

    More From Other Websites
    Medtronic Initiates Enrollment for Pivotal Diabetes IDE Study Oct 16 2014
    AbbVie sours on $55B Shire deal after tax changes Oct 16 2014
    AbbVie sours on $55B Shire deal after tax changes Oct 16 2014
    AbbVie board rejects tax-cutting inversion plan Oct 16 2014
    [video] AbbVie directors recommend against Shire deal Oct 16 2014
    Cutrale-Safra raises Chiquita takeover bid Oct 15 2014
    U.S. inversion rules cloud AbbVie-Shire deal Oct 15 2014
    AbbVie Backs Away From Shire Takeover After Tax Changes Oct 15 2014
    Shire Urges AbbVie to Pursue Merger Despite New Inversion Rules Oct 15 2014
    Medtronic Announces FDA Approval of Pacing Lead for Full-Body MRI Scans Oct 14 2014
    Medtronic Announces FDA Approval of Pacing Lead for Full-Body MRI Scans Oct 14 2014
    Medtronic Posts Positive CoreValve ADVANCE DA Study Data Oct 14 2014
    Medtronic Begins Pivotal Study of First Predictive Low Glucose Management Technology for People with... Oct 14 2014
    Capricor Therapeutics Announces Acquisition of Intellectual Property Rights to Family of Natriuretic... Oct 14 2014
    Medtronic Reveals Restructuring Plan post Covidien Buy Oct 13 2014
    Corporate Inversions: Boogeyman or Straw Man? Oct 13 2014
    EU mergers and takeovers (Oct 13) Oct 13 2014
    Medtronic seeks EU approval for $43 billion Covidien deal Oct 13 2014
    Medtronic seeks EU approval for $43 bln Covidien deal Oct 13 2014
    Medtronic seeks EU approval for $43 bln Covidien deal Oct 13 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK